Diabetes treatment in patients with renal disease: Is the landscape clear enough? (original) (raw)
Diabetic kidney disease: update on clinical management and non-glycaemic effects of newer medications for type 2 diabetes
Aine de Bhailis
Therapeutic Advances in Endocrinology and Metabolism, 2021
View PDFchevron_right
Study of metformin in diabetes mellitus with stage 3 and 4 chronic kidney disease
Denis Peeyush
Journal of Diabetes and Endocrinology Association of Nepal, 2020
View PDFchevron_right
Administration of metformin in type 2 diabetes mellitus patients with chronic kidney disease; facts and myths
Steven Kellner
Journal of Nephropathology, 2019
View PDFchevron_right
Use of metformin according to renal function in patients with type II diabetes
tahani huria
2021
View PDFchevron_right
Diabetes Treatment in Patients with Renal Disease—How Many Are Receiving Contraindicated Drugs?
Manel Mata-cases
Diabetes, 2018
View PDFchevron_right
Metformin dosage and renal protection in type 2 diabetes mellitus: Impact on estimated glomerular filtration rate
Mediterr J Pharm Pharm Sci
Mediterranean Journal of Pharmacy and Pharmaceutical Sciences, 2024
View PDFchevron_right
Appropriateness of metformin prescription for type 2 diabetes mellitus patients with chronic kidney disease (Stages 3-5)
SUBASHINI A/P CHELLAPPAH THAMBIAH / MEDIC
The Malaysian journal of pathology, 2020
View PDFchevron_right
Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register
Björn Zethelius, Jan Cederholm
BMJ open, 2012
View PDFchevron_right
Metformin and other antidiabetic agents in renal failure patients
D Me
Kidney International, 2015
View PDFchevron_right
Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
Ivan Rychlík
Kidney International, 2016
View PDFchevron_right
Metformin: Should it be the first therapeutic option in the patient with high-risk diabetes?
Augusto Cobo
Argentine Journal of Cardiology, 2021
View PDFchevron_right
Metformin in advanced chronic kidney disease: are current guidelines overly restrictive?
Pauline Swift
British Journal of Diabetes, 2016
View PDFchevron_right
Author Reply: About the discrepancies between consensus documents, clinical practice guidelines, and legal regulations in the treatment of type 2 diabetes
Carlos Morillas
Nefrologia: publicacion oficial de la Sociedad Espanola Nefrologia
View PDFchevron_right
A narrative review of new treatment options for chronic kidney disease in type 2 diabetes
Rikke Borg
Annals of Translational Medicine, 2021
View PDFchevron_right
Therapeutic management of diabetic kidney disease
Daisuke Koya
Journal of diabetes investigation, 2011
View PDFchevron_right
The Effects of Glucose-Lowering Therapies on Diabetic Kidney Disease
Varun Agrawal, Bentham Science Publishers
View PDFchevron_right
Glucose-lowering drugs in patients with chronic kidney disease: a narrative review on pharmacokinetic properties
Henk Bilo
Nephrology Dialysis Transplantation, 2013
View PDFchevron_right
Antidiabetic Medication in Patients with Chronic Kidney Disease: What's New?
Luigi Triolo
Nephrology @ Point of Care
View PDFchevron_right
Diabetic kidney disease: from physiology to therapeutics
Alberto Martínez-castelao, Jose Górriz
The Journal of Physiology, 2014
View PDFchevron_right
About the discrepancies between consensus documents, clinical practice guidelines, and legal regulations in the treatment of type 2 diabetes
Carlos Morillas
Nefrología : publicación oficial de la Sociedad Española Nefrologia, 2012
View PDFchevron_right
Spotlight on pharmacology of a noble oral hypoglycaemic agent: Metformin
World Journal of Pharmaceutical Sciences
View PDFchevron_right
Metformin: From Immediate Release to Extended Release Formula, Effectiveness, And Safety in Patients With Chronic Kidney Disease
Rodolfo Rivera
EMJ Diabetes, 2020
View PDFchevron_right
Glycaemic control and glucose-lowering therapy in diabetic patients with kidney disease
Bonaventura Mpondo
View PDFchevron_right
Quality of diabetes mellitus therapy in patients with chronic kidney disease in the real world
Antonella Paradiso
Italian Journal of Medicine, 2017
View PDFchevron_right
Novel effective drugs for diabetic kidney disease? or not
Giorgio Gentile
View PDFchevron_right
New pharmacological treatments for improving renal outcomes in diabetes
ANNE-EMILIE DECLEVES
Nature reviews. Nephrology, 2010
View PDFchevron_right
Should metformin still be the first-line of treatment in type 2 diabetes mellitus? A comprehensive review and suggested algorithm
Elamin Abdelgadir
Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2019
View PDFchevron_right
Chronic kidney disease in type 2 diabetes patients in France: Prevalence, influence of glycaemic control and implications for the pharmacological management of diabetes
C. Attali
Diabetes & Metabolism, 2012
View PDFchevron_right
Editorial: Combating Diabetes and Diabetic Kidney Disease
Keizo Kanasaki
Frontiers in Pharmacology, 2021
View PDFchevron_right
Diabetes and kidney disease
Hemachandar Radhakrishnan
To promote diabetes care, prevention and a cure …, 2004
View PDFchevron_right